Glycerol 500ml/5ml / Ipecacuanha liquid extract 980microlitres/5ml oral solution
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
MHRA licensed products
View all licensed products for Glycerol + Ipecacuanha on the MHRA register
Glycerin, Lemon and Ipecacuanha Cough Compound oral solution
Bell,Sons & Co (Druggists) Ltd
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing all 29 studies.
Reviews & meta-analyses: 11 · 2016–2022
Showing all 29 studies, sorted by most relevant.
G. Dodekatos, Stefan Schünemann, H. Tüysüz
ACS Catalysis, 2018
Mathias Klein, Steve Swinnen, J. Thevelein, et al.
Environmental microbiology, 2017
- Fungi
- Glucose
- Glycerol
There is huge variability among yeasts with regard to their efficiency in utilizing glycerol as the sole source of carbon and energy. Certain species show growth rates with glycerol comparable to those reached with glucose as carbon source; others are virtually unable to utilize glycerol, especially in synthetic medium. Most of our current knowledge regarding glycerol uptake and catabolic pathways has been gained from studying laboratory strains of the model yeast Saccharomyces cerevisiae. The growth of these strains on glycerol is dependent on the presence of medium supplements such as amino acids and nucleobases. In contrast, there is only fragmentary knowledge about S. cerevisiae isolates able to grow in synthetic glycerol medium without such supplements as well as about growth of non-Saccharomyces yeast species on glycerol. Thus, more research is required to understand why certain strains and species show superior growth performance on glycerol compared with common S. cerevisiae laboratory strains. This mini-review summarizes what is known so far about the gene products and pathways involved in glycerol metabolism and transport in yeast and fungi as well as the regulation of these processes.
Abstract licence: CC BY-NC-ND
L. Kumar, S. K. Yellapu, R. Tyagi, et al.
Bioresource technology, 2019
- Carbon
- Glycerol
- Fatty Acids
U. Nda-Umar, I. Ramli, Y. Taufiq-Yap, et al.
Catalysts, 2018
The depletion of fossil fuels has heightened research and utilization of renewable energy such as biodiesel. However, this has thrown up another challenge of significant increase in its byproduct, glycerol. In view of the characteristics and potentials of glycerol, efforts are on the increase to convert it to higher-value products, which will in turn improve the overall economics of biodiesel production. These high-value products include biofuels, oxygenated fuel additives, polymer precursors and other industrial bio-based chemicals. This review gives up-to-date research findings in the conversion of glycerol to the above high-value products, with a special focus on the performance of the catalysts used and their challenges. The specific products reviewed in this paper include hydrogen, ethanol, methanol, acetin, glycerol ethers, solketal, acetal, acrolein, glycerol carbonate, 1,3-propanediol, polyglycerol and olefins.
Abstract licence: CC BY
M. Checa, S. Nogales-Delgado, V. Montes, et al.
Catalysts, 2020
Once a biorefinery is ready to operate, the main processed materials need to be completely evaluated in terms of many different factors, including disposal regulations, technological limitations of installation, the market, and other societal considerations. In biorefinery, glycerol is the main by-product, representing around 10% of biodiesel production. In the last few decades, the large-scale production of biodiesel and glycerol has promoted research on a wide range of strategies in an attempt to valorize this by-product, with its transformation into added value chemicals being the strategy that exhibits the most promising route. Among them, C3 compounds obtained from routes such as hydrogenation, oxidation, esterification, etc. represent an alternative to petroleum-based routes for chemicals such as acrolein, propanediols, or carboxylic acids of interest for the polymer industry. Another widely studied and developed strategy includes processes such as reforming or pyrolysis for energy, clean fuels, and materials such as activated carbon. This review covers recent advances in catalysts used in the most promising strategies considering both chemicals and energy or fuel obtention. Due to the large variety in biorefinery industries, several potential emergent valorization routes are briefly summarized.
Abstract licence: CC BY
S. Verma, Shawn Lu, P. Kenis
Nature Energy, 2019
J. Tarique, S. M. Sapuan, A. Khalina
Scientific Reports, 2021
This research was set out to explore the development of arrowroot starch (AS) films using glycerol (G) as plasticizer at the ratio of 15, 30, and 45% (w/w, starch basis) using solution casting technique. The developed films were analyzed in terms of physical, structural, mechanical, thermal, environmental, and barrier properties. The incorporation of glycerol to AS film-making solution reduced the brittleness and fragility of films. An increment in glycerol concentration caused an increment in film thickness, moisture content, and solubility in water, whereas density and water absorption were reduced. The tensile strength and modulus of G-plasticized AS films were reduced significantly from 9.34 to 1.95 MPa and 620.79 to 36.08 MPa, respectively, while elongation at break was enhanced from 2.41 to 57.33%. FTIR analysis revealed that intermolecular hydrogen bonding occurred between glycerol and AS in plasticized films compared to control films. The G-plasticized films showed higher thermal stability than control films. The cross-sectional micrographs revealed that the films containing 45% glycerol concentration had higher homogeneity than 15% and 30%. Water vapour permeability of plasticized films increased by an increase in glycerol concentrations. The findings of this research provide insights into the development of bio-degradable food packaging.
Abstract licence: CC BY
Paula González Seligra, Carolina Medina Jaramillo, L. Famá, et al.
Carbohydrate polymers, 2016
- Biodegradation, Environmental
- Cross-Linking Reagents
- Dimethyl Sulfoxide
Ewelina Basiak, A. Lenart, F. Debeaufort
Polymers, 2018
As starch is an inexpensive, filmogenic, easily processable and a widely available material, it is a material that can be utilized in the creation of biodegradable films and containers, presenting as a viable alternative to polymers derived from petrol. Moreover, starch could also be used to create edible coatings for fresh foods in order to extend shelf life. As such, wheat starch films with two glycerol contents were formulated to mimic the effects of compounds currently used to coat fruit. Their structural and functional properties were characterized. This study found that the transfer properties of starch films containing 33% of plasticizer was less effective than film comprised of 50% glycerol. Water diffusivity, oxygen permeability, and water vapor permeability at two different humidity gradients, surface tension, works of surface adhesion and cohesion, and moisture sorption were tested. Glycerol content does not play a significant role on the color or mechanical properties. This work shows that glycerol can strongly affect the functional properties of starch-based coatings and films.
Abstract licence: CC BY
Abdulaal Farhan, N. M. Hani
Food Hydrocolloids, 2017
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.